TGA Approval

CINQAIR reslizumab 100 mg/10 mL concentrated solution for intravenous infusion vial (277278)

ARTG ID

277278

ARTG Name

CINQAIR reslizumab 100 mg/10 mL concentrated solution for intravenous infusion vial

Sponsor

Teva Pharma Australia Pty Ltd

ARTG Date

July 25, 2017

Registration Type

Medicine

Therapeutic Good Type

Medicine

Licence Status

Active

Licence Category

Registered

Sponsor Information

Sponsor Name

Sponsor Item Name

TEVA PHARMA AUSTRALIA PTY LTD

Ingredient Name

reslizumab

Empowering clinical research with data-driven insights and AI-powered tools.

CINQAIR reslizumab 100 mg/10 mL concentrated solution for intravenous infusion vial (277278) - TGA 批准文号 | MedPath